emgality

navigate by keyword : autoinjection autoinjector block box cgrp chronic device dose drug emgality episodic galcanezumab gnlm headache home use hope illustrative editorial injection instructions leaflet medical medication medicine migraine new packaging pain pharmaceutical prefilled prescription prevent preventative prevention product receptor reduce revolutionary single subcutaneous syringe treat treatment

Delft, The Netherlands - February 8, 2023: Emgality, Galcanezumab autoinjector migraine prevention medication Royalty Free Stock Photo
Delft, The Netherlands - February 3, 2023: Autoinjector pen for migraine, prevention medication cgrp Royalty Free Stock Photo
Seattle, WA USA - circa May 2022: Close up view of an angled bottle of Topiramate medication Royalty Free Stock Photo
Seattle, WA USA - circa July 2022: Close up, selective focus on Ubrelvy medication against a white background Royalty Free Stock Photo
Seattle, WA USA - circa July 2022: Close up, selective focus on Ubrelvy medication against a white background Royalty Free Stock Photo
   
   
Emgality injection, one of four recently approved migraine prevention medications.
Seattle, WA USA - circa May 2022: Angled view of a bottle of Topiramate medication on a white counter top Royalty Free Stock Photo
   
   
   
   
   
   
Close up of Emgality injection. Emgality (galcanezumab-gnlm) is one of four recently FDA approved migraine prevention medications.


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.